Katherine Stueland - 30 Sep 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
30 Sep 2025
Net transactions value
-$1,390,911
Form type
4
Filing time
01 Oct 2025, 16:21:01 UTC
Previous filing
18 Sep 2025
Next filing
31 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stueland Katherine CHIEF EXECUTIVE OFFICER, Director C/O GENEDX HOLDINGS CORP., STAMFORD /s/ Bridget Brown, Attorney-in-Fact 01 Oct 2025 0001689575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Sale $63,690 -606 -4.2% $105.10 13,972 30 Sep 2025 Direct F1, F2
transaction WGS Class A Common Stock Sale $116,506 -1,092 -7.8% $106.69 12,880 30 Sep 2025 Direct F1, F3
transaction WGS Class A Common Stock Sale $480,160 -4,462 -35% $107.61 8,418 30 Sep 2025 Direct F1, F4
transaction WGS Class A Common Stock Sale $560,457 -5,163 -61% $108.55 3,255 30 Sep 2025 Direct F1, F5
transaction WGS Class A Common Stock Sale $60,458 -554 -17% $109.13 2,701 30 Sep 2025 Direct F1, F6
transaction WGS Class A Common Stock Sale $22,046 -200 -7.4% $110.23 2,501 30 Sep 2025 Direct F1
transaction WGS Class A Common Stock Sale $72,134 -645 -26% $111.84 1,856 30 Sep 2025 Direct F1, F7
transaction WGS Class A Common Stock Sale $15,460 -136 -7.3% $113.68 1,720 30 Sep 2025 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.98, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive.
F8 Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.